Table 2.

Twelve-month outcomes in efficacy and safety measures (N = 62 eyes of 42 subjects)

Variable	Baseline	12-Month follow-up	p-value
Intraocular pressure (mmHg)	15.82 ± 2.94 [9–20]	12.32 ± 2.58 [8–18]	< 0.001*
Glaucoma medications	1.50 ± 1.28 [0–5]	0.45 ± 0.86 [0–4]	< 0.001*
Corrected distance visual acuity (logMar)	0.17 ± 0.21 [0.0–1.0]	0.04 ± 0.09 [0.0–0.4]	< 0.001*
Cup-to-disc ratio	0.71 ± 0.14 [0.40–0.95]	0.73 ± 0.12 [0.40–0.95]	0.527
Visual field—mean deviation (dB)	− 5.62 ± 5.16 [− 29.0 to − 0.5]	− 5.97 ± 5.00 [− 29.0 to − 0.5]	0.602
Visual field—pattern standard deviation (dB)	4.76 ± 2.98 [2–13]	4.38 ± 2.74 [1–12]	0.483
Retinal nerve fiber layer thickness (μm)	76.94 ± 13.09 [52–114]	77.75 ± 14.14 [50–114]	0.777

Mean ± standard deviations are presented and statistically compared

*Denotes statistical significance

[] Represents range